humanized glp-1 receptor knock-in mouse The Obesity Science & Innovation 2025: Generation of GIPR Mice for Obesity and Diabetes Preclinical JCI - Pancreatic GLP-1 receptor

The inhibitory effect of GLP-1 on gastric emptying is dose-dependent, and the use of lower doses of GLP-1 in patients with T2DM may also be suitable for blood glucose control (141)

The short answer: You can begin with your primary care clinician, a specialist in obesity medicine, or in some cases a telehealth provider

Plus, we serve patients in 48 states, and no insurance is required to get started

In the LEADER trial, liraglutide demonstrated cardiovascular benefit, and GLP1RAs have similar effects, aligning with liraglutides anti-atherosclerotic effect

For instance, patients using liraglutide (Saxenda), which is specifically approved for weight loss, typically experience average weight reductions of approximately 57% of their initial body weight after one year

Individual health history can make one option more appropriate, less appropriate, or unsuitable